Procedure-aware
Safety focused
Women’s Health Clinic FAQ
Where is the O-Shot injected and what are the injection sites?
It is natural to want to know exactly where injections go, but intimate PRP should be planned around the patient’s symptoms, anatomy and consent rather than a universal diagram.
Direct answer
O-Shot injection sites vary according to symptoms, anatomy, consent and clinical judgement. PRP may be placed into selected vulval, clitoral or anterior vaginal wall tissues, but it should not be described as one resolved injection map for every patient. The clinician should explain the intended sites, why they are relevant, what sensation to expect, and when treatment should be delayed because of infection, pain, bleeding or other concerns.
The safest next step is to separate the symptom pattern from the treatment name, then decide whether PRP, another pathway or combined care is more appropriate.
Educational only. Suitability must be confirmed after consultation. Results vary. Not a cure.
At a glance
These are the key points to understand before considering PRP for O-Shot injection sites.
At a glance
Clinical summary
First step
Clarify the symptom pattern before choosing treatment.
May suit
Selected tissue-related symptoms after assessment.
Evidence status
Evidence is developing; response and protocols vary.
Not a shortcut
Pain, infection, skin disease or surgical concerns need review first.
Important suitability note
New, severe, worsening or unexplained symptoms should be assessed before elective intimate treatment.
PRP
Assessment
Safety
Aftercare
Detailed answer
What to understand about O-Shot injection sites
Procedure and recovery questions deserve practical, calm answers that explain what is expected, what varies and when to seek help.
Clinical context
Injection planning may consider clitoral sensitivity, anterior vaginal wall symptoms, tissue quality, dryness, discomfort, urinary support or scar sensitivity, but only after assessment.
Pain pattern
Pelvic floor
Alternatives
What the O-Shot is
A blood sample is processed to concentrate platelets. The platelet-rich plasma is then injected into selected intimate tissue after consent and numbing.
How it may work
Platelet signalling proteins are involved in repair pathways such as collagen support, blood-vessel formation, hydration and tissue resilience.
What it does not replace
PRP does not replace diagnosis, infection checks, vulval skin assessment, pelvic-floor review, specialist referral or established treatment where needed.
Why symptoms matter
Location, trigger, severity, timing, associated bleeding, discharge, urinary change or numbness can all change the clinical pathway.
What this means in practice
Established options such as moisturisers, lubricants, local hormone discussion, vulval care, scar care, pelvic-floor support or specialist review may be needed before or alongside PRP.
If PRP is suitable, the aim is usually gradual tissue support rather than an instant or certain response. Non-response should lead to reassessment.
Patient safety
Why clear preparation matters
A good procedure page reduces uncertainty without pretending that every patient has the same experience.
It identifies the cause
The right treatment depends on whether symptoms are linked to tissue change, skin disease, infection, pelvic-floor function, scarring, nerves or hormones.
It protects safety
Bleeding, unusual discharge, fever, severe pain, new numbness or urinary change should be reviewed before elective intimate treatment.
It avoids over-treatment
Some patients need conservative care, medication, pelvic-floor support, specialist review or monitoring rather than PRP first.
It sets expectations
PRP response is gradual and variable. It may support tissue quality, but it cannot promise one predictable outcome.
A careful symptom map comes first
A good consultation asks what has changed, when it happens, where it is felt, what makes it worse and what treatments have already been tried.
That distinction helps decide whether PRP is worth discussing, whether another pathway should come first, or whether combined care is more appropriate.
Considerations
What to confirm with the clinic
Before treatment, make sure the procedure, consent, comfort measures, aftercare and escalation advice are clear.
Consultation priorities
Your clinician should review symptoms, medical history, medication, vulval skin, pain pattern, urinary symptoms, previous treatment and goals before discussing PRP.
Examination
Consent
Follow-up
Before treatment
You may need review for infection, abnormal bleeding, vulval skin change, pelvic pain, medication effects, surgery history or menopause-related tissue change.
During the procedure
If PRP is chosen, the appointment usually involves consent, cleansing, blood draw, centrifuge preparation, numbing and targeted injections.
Aftercare
Aftercare commonly includes avoiding sex, baths and swimming for 24 to 48 hours while injection points settle, plus advice on symptoms to report.
When to reassess
If symptoms continue, worsen or change pattern, the plan should be reviewed rather than assuming repeat PRP is the answer.
Practical expectations
Pricing and treatment plans should be confirmed on the /pricing/ page or with the clinic before booking.
A follow-up discussion is useful if symptoms do not improve, discomfort persists, or the pattern suggests a different underlying cause.
Common concerns and myths
Common misunderstandings
Clear expectations prevent both unnecessary worry and over-confident assumptions about intimate procedures.
Myth: the O-Shot has one resolved injection site
Reality: injection sites should be individualised and explained before treatment, with consent for each relevant area.
Myth: symptoms should be hidden
Reality: intimate symptoms are common enough to discuss and important enough to assess properly.
Myth: no assessment is needed
Reality: symptoms can overlap with infection, skin disease, pelvic-floor pain, nerve symptoms, scarring and menopause-related change.
Evidence and uncertainty
Research into vaginal PRP is growing, but preparation methods, injection protocols and outcome measures vary, so cautious language is important.
Alternatives and combined care
Conservative care, local hormone options, vulval treatment, scar care, pelvic-floor care, pain management or specialist referral may be more appropriate first.
Safety checklist
Safety checklist
Use these questions to decide whether the next step should be consultation, further assessment, treatment planning or urgent advice.
Has the cause been assessed?
Symptoms should be mapped by pattern, medical history, medication, menopause status, surgery or childbirth history and any pain, bleeding or discharge.
Are symptoms stable?
New, severe, worsening or unexplained symptoms should be reviewed before an elective intimate procedure.
Are options clear?
Ask how PRP compares with conservative care, medication, pelvic-floor support, specialist review or other relevant options.
Is follow-up planned?
You should know what to expect, what aftercare to follow, when to seek help and when the response will be reviewed.
Reassuring signs
It is more reasonable to discuss PRP when symptoms have been assessed, red flags are absent, goals are realistic and alternatives have been explained.
Realistic goals
Aftercare clear
Reasons to pause
Pause and seek medical review if symptoms include unexplained bleeding, unusual discharge, fever, severe pain, new numbness, vulval lesions or sudden urinary change.
Infection signs
New numbness
When to escalate
When to seek medical help
Some symptoms should be assessed promptly before any elective intimate treatment is considered. Use NHS 111 online
Severe or worsening pain
Seek medical advice if pelvic, vulval or vaginal pain is severe, sudden, worsening or unexplained.
Bleeding or discharge
Unexplained bleeding, bleeding after sex, foul-smelling discharge or unusual discharge should be reviewed before treatment.
Infection signs
Fever, feeling unwell, spreading redness, pus, worsening swelling or urinary infection symptoms need prompt clinical advice.
New numbness or bladder change
Sudden genital numbness, numbness into the legs, new weakness or sudden bladder change should be assessed urgently.
Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.
Regulatory resources
Authoritative resources
These resources support assessment-led, evidence-aware information about intimate procedures, aftercare, symptom escalation and realistic expectations.
NHS 111 urgent advice
NHS 111 supports patients who need urgent advice for worrying symptoms after a procedure.
NICE menopause guideline
NICE guidance supports careful assessment of menopause-related genitourinary symptoms and treatment decisions.
NHS guidance on vaginal dryness
NHS patient guidance helps frame common intimate symptoms and when clinical review is appropriate.
Next step
Book a clinical consultation
A consultation can confirm whether treatment should go ahead, what will happen on the day, and what aftercare and review plan are appropriate.
▶ View Research Sources (12 Sources)
These 12 source names are selected from 24 display-ready sources, with a raw audit trail of 53 imported records. Additional reviewed material included evidence reviews; duplicate, low-relevance and non-clinical records were removed before display.
Educational only. This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. The O-Shot is an off-label, investigational PRP procedure in this context, and suitability must be confirmed after individual consultation. Results vary. Not a cure.
